# The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine

> **NCT05536466** · NA · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 8 (estimated)

## Conditions studied

- HIV Infections
- Bariatric Surgery Candidate

## Interventions

- **PROCEDURE:** bariatric surgery

## Key facts

- **NCT ID:** NCT05536466
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-30
- **Primary completion:** 2023-07-23
- **Final completion:** 2023-08-01
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2022-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05536466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05536466, "The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05536466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*